Position in SCLX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,697
+$541 QoQ
Shares Held
474
-37.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 72 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MCF Advisors LLC holds $26,128,918 across 16 Drug Manufacturers - General names. SCLX ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,362 | $6,441,187 | |
| 2 | AMGN |
Amgen Inc
|
12,335 | $4,466,750 | |
| 3 | LLY |
ELI LILLY & Co
|
3,535 | $4,239,985 | |
| 4 | ABBV |
AbbVie Inc.
|
12,627 | $3,177,458 | |
| 5 | MRK |
Merck & Co., Inc.
|
23,882 | $3,068,837 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
21,492 | $2,715,299 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,023 | $980,865 | |
| 8 | PFE |
Pfizer Inc
|
27,882 | $671,398 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,697 | 474 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,156 | 474 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,782 | 474 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $9,328 | 474 | Shares | Sole | 2025-11-05 | |
| No filing history on record for this holder in this stock. | ||||||